This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.
This AI-driven security firm, known for touchless screening systems, reported a notable insider sale amid strong one-year share gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback